ALDX - Aldeyra Therapeutics 10% owner disposes stake worth $4.45M
2023-10-19 14:25:47 ET
More on Aldeyra Therapeutics
- Eyeing Returns: Aldeyra's Shift From Lab To Market
- Aldeyra says FDA may not approve dry eye drug, stock plunges 69% (update)
- Seeking Alpha’s Quant Rating on Aldeyra Therapeutics
- Historical earnings data for Aldeyra Therapeutics
For further details see:
Aldeyra Therapeutics 10% owner disposes stake worth $4.45M